Coriandrum sativum L. (Coriander) essential oil: Antifungal activity and mode of action on Candida spp., and molecular targets affected in human whole-genome expression

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Freires, Irlan De Almeida ^a   Murata, Ramiro Mendonça ^b   Furletti, Vivian Fernandes ^a   Sartoratto, Adilson ^a   De Alencar, Severino Matias ^c   Figueira, Glyn Mara ^a   Rodrigues, Janaina Aparecida De Oliveira ^c   Duarte, Marta Cristina Teixeira ^a   Rosalen, Pedro Luiz ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; CD51 ANTIGEN; CHEMOKINE; ERGOSTEROL; ESSENTIAL OIL; INTERLEUKIN 6; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; POLYSTYRENE; PROTEIN C FOS; PROTEIN C JUN; SESQUITERPENE; TERPENE; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 10; VERY LATE ACTIVATION ANTIGEN 11; VERY LATE ACTIVATION ANTIGEN 2; VERY LATE ACTIVATION ANTIGEN 3; VERY LATE ACTIVATION ANTIGEN 4; VERY LATE ACTIVATION ANTIGEN 5; VERY LATE ACTIVATION ANTIGEN 6; VERY LATE ACTIVATION ANTIGEN 8; ANTIFUNGAL AGENT; CELL ADHESION MOLECULE;

ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; APOPTOSIS; ARTICLE; BIOFILM; BIOSYNTHESIS; CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA KRUSEI; CANDIDA RUGOSA; CANDIDA TROPICALIS; CELL DEATH; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORIANDER; CYTOTOXICITY; DRUG ACTIVITY; DRUG POTENTIATION; FUNGAL STRAIN; GENE EXPRESSION; HUMAN; HUMAN CELL; ION PERMEABILITY; MEMBRANE DAMAGE; MICROPHOTOGRAPHY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYTOCHEMISTRY; PLANT LEAF; PROTEIN DEGRADATION; YEAST CELL; CHEMISTRY; CORIANDRUM; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HELA CELL LINE; HUMAN GENOME; METABOLISM; MICROBIAL SENSITIVITY TEST; PHYSIOLOGY;

ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA; CELL ADHESION MOLECULES; CHEMOKINES; CORIANDRUM; ERGOSTEROL; GENE EXPRESSION REGULATION; GENOME, HUMAN; HELA CELLS; HUMANS; MICROBIAL SENSITIVITY TESTS; MITOGEN-ACTIVATED PROTEIN KINASES; OILS, VOLATILE; PLANT LEAVES;

EID: 84902593534     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099086     Document Type: Article

References (61)

1. Samaranayake LP, Fidel PL, Naglik JR (2002) Fungal infections associated with HIV infection. Oral Disease 8: 151-160. (Pubitemid 41758956)
2. Colombo AL, Nucci M, Park BJ, Nouér SA, Arthington-Skaggs B, et al. (2006) Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol 44: 2816-2823. (Pubitemid 44228575)
3. Pfaller M, Neofytos D, Diekema D, Azie N, Meier-Kriesche H, et al. (2012) Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance) registry, 2004-2008. Diag Microbiol Infect Dis 74: 323-331.
4. Messer SA, Moet GJ, Kirby JT, RN Jones (2009) Activity of contemporary antifungal agents, including the novel echinocandin Anidulafungin, tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: Report from the SENTRY Antimicrobial Surveillance Program (2006 to 2007). J Clin Microbiol 47: 1942-1946.
5. Berman J, Sudbery PE (2002) Candida albicans: a molecular revolution built on lessons from budding yeast. Nat Rev Genet 3: 918-930. (Pubitemid 35423504)
6. Kuhn DM, Ghannoum MA (2004) Candida biofilms: antifungal resistance and emerging therapeutic options. Curr Opin Investig Drugs 5: 186-197.
7. Ramage G, Rajendran R, Sherry L, Williams C (2012) Fungal biofilm resistance. Int J Microbiol 2012: 528521. doi:10.1155/2012/528521.
8. Newman DJ, Cragg GM (2012) Natural Products as Sources of New Drugs over the 30 Years from 1981 to 2010. J Nat Prod 75: 311-335.
9. Silva F, Ferreira S, Duarte A, Mendonça DI, Domingues FC (2011) Antifungal activity of Coriandrum sativum essential oil, its mode of action against Candida species and potential synergism with amphotericin B. Phytomedicine 19: 42-47.
10. Asgarpanah J, Kazemivash N (2012) Phytochemistry, pharmacology and medicinal properties of Coriandrum sativum L. African J Pharm Pharm 6: 2340-2345.
11. Snigdha C, Monika T (2013) Coriandrum sativum: A promising functional and medicinal food. Int J Phytomed Related Industr 5: 59-65.
12. Galvão LCC, Furletti VF, Bersan SMF, Cunha MG, Ruiz ALTG, et al. (2012) Antimicrobial Activity of Essential Oils against Streptococcus mutans and their Antiproliferative Effects. Evid Based Complem Altern Med, doi:10.1155/2012/751435.
13. Harsha SN, Anilakumar KR (2012) In vitro free radical scavenging and DNA damage protective property of Coriandrum sativum L. leaves extract. J Food Sci Technol, doi:10.1007/s13197-012-0648-5.
14. Sreelatha S, Padma PR, Umadevi M (2009) Protective effects of Coriandrum sativum extracts on carbon tetrachloride-induced hepatotoxicity in rats. Food Chem Toxicol 47: 702-708.
15. Emamghoreishi M, Heidari-Hamedani GH (2008) Effect of extract and essential oil of Coriandrum sativum seed against pentylenetetrazole-induced seizure. Pharm Sci 7: 1-10.
16. Furletti VF, Teixeira IP, Obando-Pereda G, Mardegan RC, Sartoratto A, et al. (2011) Action of Coriandrum sativum L. essential oil upon oral Candida albicans biofilm formation. Evid Based Complem Altern Med, doi:10.1155/2011/ 985832.
17. Soares BV, Morais SM, Fontenelle ROS, Queiroz VA, Vila-Nova NS, et al. (2012) Antifungal activity, toxicity and chemical composition of the essential oil of Coriandrum sativum L. Fruits. Molecules 17: 8439-8448. doi:10.3390/molecules17078439.
18. Matasyoh JC, Maiyo ZC, Ngure RM, Chepkorir R (2009) Chemical composition and antimicrobial activity of the essential oil of Coriandrum sativum. Food Chem 113: 526-529.
19. Adams RP (2007) Identification of Essential Oils Components by Gas Chromatography/Mass Spectrometry, Allured, Carol Stream, Ill, USA.
20. Clinical and Laboratory Standards Institute (CLSI) (2002) Protocol M27-A2. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. 2.ed. Pennsylvania: NCCLS, 51p.
21. Siddiqui ZN, Farooq F, Musthafa TNM, Ahmad A, Khan AU (2013) Synthesis, characterization and antimicrobial evaluation of novel halopyrazole derivatives. J Saudi Chem Soc 17: 237-243.
22. Frost DJ, Brandt KD, Cugier D, Goldman RJ (1995) A whole-cell Candida albicans assay for the detection of inhibitors towards fungal cell wall synthesis and assembly. J Antibiotic 48: 306-310.
23. Escalante A, Gattuso M, Pérez P, Zacchino S (2008) Evidence of the mechanism of action of the antifungal phytolaccoside B isolated from Phytolacca tetramera Hauman. J Nat Prod 71: 1720-1725.
24. Lima IO, Pereira FO, Oliveira WA, Lima EO, Menezes EA, et al. (2013) Antifungal activity and mode of action of carvacrol against Candida albicans strains. J Essential Oil Res 25: 138-142.
25. Djordjevic D, Wiedmann M, McLandsborough LA (2002) Microtiter plate assay for assessment of Listeria mono-cytogenes biofilm formation. Applied Environm Microbiol 68: 2950-2958. (Pubitemid 34602018)
26. Rodrigues JAO, Höfling JF, Azevedo RA, Gabriel DL, Tamashiro WMSC (2007) Production of monoclonal antibodies for detection of a secreted aspartyl proteinase from Candida spp. in Biologic Specimens. Hybridoma 26: 201-210.
27. Price MF, Wilkinson ID, Genty LO (1982) Plate method for detection of phospholipase activity in Candida albicans. Saboraudia 20: 7-14. (Pubitemid 12161206)
28. Drago L, Mombelli B, De Vecchi E, Bonaccorso C, Fassina MC, et al. (2000) Candida albicans cellular internalization: a new pathogenic factor? Int J Antimicrob Agents 16: 545-547.
29. Skloot R (2010) The immortal life of Henrietta Lacks. New York: Crown Publishers.
30. Sahib NG, Anwar F, Gilani AH, Hamid AA, Saari N, et al. (2012) Coriander (Coriandrum sativum L.): A Potential Source of High-Value Components for Functional Foods and Nutraceuticals- A Review. Phytother. Res. doi:10.1002/ptr.4897.
31. Potter TL (1996) Essential oil of cilantro. J Agri Food Chem 44: 1824-1826.
32. Bhuiyan MNI, Begum J, Sulatana M (2009) Chemical composition of leaf and seed essential oil of Coriandrum sativum L. from Bangladesh. J Pharmacol 4: 150-153.
33. Eyres G, Dufour JP, Hallifax G, Sotheeswaran S, Marriott PJ (2005) Identification of character-impact odorants in coriander and wild coriander leaves using gas chromatography olfactometry (GCO) and comprehensive two-dimensional gas-chromatography-time of flight mass spectrometry (GCx GCTOFMS). J Sep Sci 28: 1061-1074. (Pubitemid 40909110)
34. Begnami AF, Duarte MCT, Furletti V, Rehder VLG (2010) Antimicrobial potential of Coriandrum sativum L. against different Candida species in vitro. Food chem 118: 74-77.
35. Duarte MCT, Leme EE, Delarmelina C, Soares AA, Figueira GM, et al. (2007) Activity of essential oils from Brazilian medicinal plants on Escherichia coli. J Ethnopharmacol 111: 197-201. (Pubitemid 46528066)
36. Jeon JG, Rosalen PL, Falsetta ML, Koo H (2011) Natural Products in Caries Research: Current (Limited) Knowledge, Challenges and Future Perspective. Caries Res 45: 243-263.
37. Delaquis PJ, Stanich K, Girard B, Mazza G (2002) Antimicrobial activity of individual and mixed fractions of dill, cilantro, coriander and eucalyptus essential oils. Int J Food Microbiol 74: 101-109. (Pubitemid 34203708)
38. Cal K (2006) Skin penetration of terpenes from essential oils and topical vehicles. Planta Med 72: 311-316.
39. Bakkali F, Averbeck S, Averbeck D, Idaomar M (2008) Biological effects of essential oils - a review. Food Chem Toxicol 46: 446-475. (Pubitemid 350297552)
40. Pauli A (2006) Anticandidal low molecular compounds from higher plants with special reference to compounds from essential oils. Med Res Rev 26: 223-268.
41. Ghannoum MA Rice LB (1999) Antifungal agents: Mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev 12: 501-517. (Pubitemid 29484744)
42. Pierce CG, Srinivasan A, Uppuluri P, Ramasubramanian AK, López-Ribot JL (2013) Antifungal therapy with an emphasis on biofilms. Curr Opinion Pharmacol 13: 726-730.
43. Müller C, Staudacher V, Krauss J, Giera M, Bracher F (2013) A convenient cellular assay for the identification of the molecular target of ergosterol biosynthesis inhibitors and quantification of their effects on total ergosterol biosynthesis. Steroids 78: 483-493.
44. Silva F, Ferreira S, Queiroz JA, Domingues FC (2011) Coriander (Coriandrum sativum L.) essential oil: its antibacterial activity and mode of action evaluated by flow cytometry. J Med Microbiol 60: 1479-1486.
45. Lopes G, Pinto E, Andrade PB, Valenta P (2013) Antifungal Activity of Phlorotannins against Dermatophytes and Yeasts: Approaches to the Mechanism of Action and Influence on Candida albicans Virulence Factor. PloS ONE 8: e72203. doi:10.1371/journal.pone.0072203.
46. Sun N, Fonzi W, Chen H, She X, Zhang L, et al. (2013) Azole Susceptibility and Transcriptome Profiling in Candida albicans Mitochondrial Electron Transport Chain Complex I Mutants. Antimicrob Agents Chemother 57: 532-542.
47. Ramage G, Mowat E, Jones B, Williams C, Lopez-Ribot J (2009) Our current understanding of fungal biofilms. Crit Rev Microbiol 35: 340-355.
48. Ramage G, Rajendran R, Sherry L, Williams C (2012) Fungal biofilm resistance. Int J Microbiol 2012: 528521. doi:10.1155/2012/528521.
49. Hasan F, Xess I, Wang X, Jain N, Fries BC (2009) Biofilm formation in clinical Candida isolates and its association with virulence. Microbes Infect 11: 753-761.
50. Kajfasz JK, Rivera-Ramos I, Abranches J, Martinez AR, Rosalen PL et al (2010) Two Spx proteins modulate stress tolerance, survival, and virulence in Streptococcus mutans. J Bacteriol 192: 2546-2556.
51. Ramage G, Saville SP, Thomas DP, López-Ribot JL (2005) Candida biofilms: an update. Eukaryotic Cell 4: 633-8. (Pubitemid 40600417)
52. Rane HS, Bernardo SM, Howell AB, Lee SA (2013) Cranberry-derived proanthocyanidins prevent formation of Candida albicans biofilms in artificial urine through biofilm- and adherence-specific mechanisms. J Antimicrob Chemother. E-pub ahead of print. doi:10.1093/jac/dkt398.
53. Wächtler B, Citiulo F, Jablonowski N, Förster S, Dalle F, et al. (2012) Candida albicans-epithelial interactions: dissecting the roles of active penetration, induced endocytosis and host factors on the infection process. PLoS One 7:e36952; PMID:22606314; http://dx.doi.org/10.1371/journal. pone.0036952.
54. Naglik JR, Challacombe SJ, Hube B (2003) Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev; 67: 400-28; PMID:12966142; http://dx.doi.org/10.1128/MMBR.67.3.400-428.2003.
55. Höfling JF, Mardegan RC, Anibal PC, Furletti VF, Foglio MA (2011) Evaluation of Antifungal Activity of Medicinal Plant Extracts Against Oral Candida albicans and Proteinases. Mycopathol 172: 117-124.
56. Vermelho AB, Meirelles MNL, Lopes A, Petinate SDG, Chaia AA, et al. (1996) Detection of extracellular proteases from microorganisms on agar plates. Mem Inst Oswaldo Cruz 91: 755-760. (Pubitemid 126479343)
57. Kantarcioglu AS, Yucel A (2002) Phospholipase and protease activity in clinical Candida isolates with reference to the sources of strains. Mycoses 5: 160-165.
58. Vaishali C, Jain PC (2012) Screening of alkaline protease production by fungal isolates from different habitats of Sagar and Jabalpur district (M.P). J. Acad. Indus. Res 1: 215-220.
59. Guba R (2001) Toxicity myths - essential oils and their carcinogenic potential. Int J Aromather 11: 76-83.
60. Burdock GA, Carabin IG (2009) Safety assessment of coriander (Coriandrum sativum L.) essential oil as a food ingredient. Food Chem Toxicol 47: 22-34.
61. Özbek H, Him A, Turkozu D (2006) The levels of lethal dose and anti-inflammatory effect of Coriandrum sativum L. essential oil extract. Ege J Med 45: 163-167.